A Study of NCS-01 in Patients With Acute Ischemic Stroke

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is an initial Phase1/2 dose‐finding, randomized, multi‐center study to evaluate the safety and tolerability of NCS‐01 in patients with acute ischemic stroke. All patients will be randomized within 48 hours of stroke onset. This study will be conducted in 2 stages.
Epistemonikos ID: 0e208a3e9649aca603b3ddfda25a209b6b18b827
First added on: May 22, 2024